“Anti-Tumor Activity of Cabozantinib by FAK down-Regulation in Human Oral Squamous Cell Carcinoma”. 2015. Bangladesh Journal of Pharmacology 11 (1): 119-25. https://doi.org/10.3329/bjp.v11i1.24001.